Skip to main content
. Author manuscript; available in PMC: 2021 Jul 13.
Published in final edited form as: JACC Cardiovasc Interv. 2020 Jun 10;13(13):1515–1525. doi: 10.1016/j.jcin.2020.04.029

Table 3:

Outcomes divided by pre-operative risk of mortality, reason for reoperation, and timing of repair.

Variable Overall (N=123) Preoperative Risk of Mortality Indication for Reoperation Timing to Reoperation*
Low (<4%) (N=21) Medium (4–8%) (N=30) High (>8%) (N=72) Prosthetic Deterioration (N=20) Endocarditis (N=12) Perivalvular Leak, Sizing/Position, or Failed Repair (N=45) <1 Month (N=15) 1–12 Months (N=24) >12 Months (N=15)
Operative Mortality 21 (17.1%) 3 (14.3%) 3 (10.0%) 15 (20.8%) 3 (15.0%) 3 (25.0%) 11 (24.4%) 2 (12.5%) 4(14.8%) 3 (20.0%)
Discharge Location
 Home 44 (43.1%) 16 (88.9%) 13 (48.2%) 15 (26.3%) 11 (64.7%) 3 (33.3%) 13 (38.2%) 6 (42.9%) 11 (47.8%) 9 (75.0%)
 Extended Care/TCU 46 (45.1%) 2 (11.1%) 11 (40.7%) 33 (57.9%) 5 (29.4%) 3 (33.3%) 17 (50.0%) 7 (50.0%) 9(39.1%) 2 (16.7%)
 Nursing Home 4 (3.9%) 0 2 (7.4%) 2 (3.5%) 0 1 (11.1%) 2 (5.9%) 0 1 (4.4%) 0
 Other Hospital 7 (6.9%) 0 1 (3.7%) 6(10.5%) 1 (5.9%) 2 (22.2%) 1 (2.9%) 1 (7.1%) 2 (8.7%) 1 (8.3%)
Stroke 4 (3.3%) 1 (4.8%) 0 3 (4.2%) 1 (5.0%) 0 1 (2.2%) 0 0 0
Reoperation 17 (13.8%) 5 (23.8%) 4 (13.3%) 8(11.1%) 2 (10.0%) 1 (8.3%) 10 (22.2%) 2 (12.5%) 2 (7.4%) 0
Prolonged Ventilation 50 (40.7%) 4 (19.1%) 8 (26.7%) 38 (52.8%) 7 (35.0%) 6 (50%) 21 (46.7%) 8 (50.0%) 9 (33.3%) 6 (40.0%)
New Renal Failure 12 (10.4%) 1 (4.8%) 3 (10.3%) 8(12.3%) 2 (11.1%) 2 (22.2%) 6(14.0%) 0 2 (8.7%) 2 (14.3%)
New Atrial Fibrillation 29 (35.4%) 5 (29.4%) 8 (38.1%) 16 (36.4%) 5 (31.3%) 1 (12.5%) 11 (39.3%) 3 (33.3%) 6 (46.2%) 2 (14.3%)
New Permanent Pacemaker/ICD 18 (14.6%) 5 (23.8%) 4 (13.3%) 9 (12.5%) 4 (20.0%) 3 (25.0%) 4 (8.9%) 3 (18.8%) 5(18.5%) 3 (20.0%)
*

July 2011-June 2014 only

Prolonged Ventilation – Greater than 24 hours. TCU – Transitional Care Unit